We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

Sidley Austin LLP global pricing newsletter - volume three 2014

  • Sidley Austin LLP
  • -
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • -
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare

Updates on international pricing issues for pharmaceutical and biologic products

  • Sidley Austin LLP
  • -
  • China, European Union, France, Germany, United Kingdom, USA
  • -
  • May 18 2012

Sidley Austin LLP’s Global Life Sciences Team is pleased to provide you with this Global Pricing Newsletter, the first in a periodic series updating clients and friends of the firm on pricing issues around the world that may have an impact on pharmaceutical and biologic manufacturers’ legal and business strategies

Heraeus Kulzer GmbH v. Biomet, Inc., 633 F.3d 591 (7th Cir. Jan. 24, 2011)

  • Sidley Austin LLP
  • -
  • Germany, USA
  • -
  • May 5 2011

The Seventh Circuit ruled that petitioner Heraeus Kulzer was entitled to obtain discovery in the United States pursuant to 28 U.S.C. 1782 in support of its trade secret lawsuit against Biomet in German court

Stricter interpretation of Safe Harbor principles by German data protection authorities (due diligence requirements)

  • Sidley Austin LLP
  • -
  • Germany, USA
  • -
  • June 22 2010

German data protection authorities have placed a significant new duty on German companies transferring personal data to US companies on the basis of the Safe Harbor principles to inquire into the compliance practices of the US Safe Harbor member